$BSEM ($BSEM) is expected to release its quarterly earnings data on Monday, April 7th after market close, per Finnhub. Analysts are expecting revenue of $88,418,700 ...

BioStem Technologies, Inc. engages in the provision of regenerative medicine and anti-aging solutions. It offers pre-treatment assessment, cell therapies, anti-aging, and wellness compounds. The ...

Shares of BioStem Technologies (OTCPK:BSEM) traded higher on Tuesday after the company announced that the Center for Medicaid and Medicare Services (CMS) has established national pricing for its wound ...

Nasdaq listing aims to increase market visibility and global liquidity opportunities as BioStem advances its commercial and clinical initiatives amid record revenue growth POMPANO BEACH, Fla., Sept.

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Reveal insider sentiment with alternative data that tracks buy and sell trades made by top managers and company directors.